February 26, 2025 | Alexandria Center for Life Science, 188 E Blaine St, Seattle, WA 98102 | 11:30 AM - 1:30 PM PT
How to Get the Most Out of Your Preclinical Trials
From concept to cohort: case studies on the complexities of preclinical mouse models
We invite you to join leading preclinical researchers to explore the best practices and pitfalls in conducting preclinical research, particularly with mouse models. Through this presentation, you can expect to learn how to plan out trials ahead of time to avoid pitfalls and promote success, as well as what models work best for different therapeutic areas.
Taconic Biosciences is committed to empowering investigators with the tools, models, and expertise needed to advance preclinical research, drug development, and ultimately human health. We offer a diverse portfolio of off-the-shelf mouse and rat models for various therapeutic areas, such as oncology, immuno-oncology, neuroscience, metabolic disease, and inflammatory bowel disease. Our customized scientific services include custom model development, colony management, and microbiome solutions, delivering personalized support to drive scientific discovery. This educational presentation will illuminate that Taconic Biosciences is more than a vendor, we are your trusted partner for driving preclinical success using case studies that emphasize the complexities of preclinical mouse models.
Key Information:
- When: Wednesday, February 26th
- What: Lunch & Learn Presentation "How to Get the Most Out of Your Preclinical Trials"
- Presented by: Jessica Ramadhin, PhD & Lisa Goldberg, PhD
- Time: 11:30-1:30 pm Pacific Time
- Where: Alexandria Center for Life Science, The Union Conference Center, 188 E Blaine St, Seattle, WA 98102
Meet the Presenters
Presenter
Lisa Goldberg, PhD 
Director, Scientific Program Management
Taconic Biosciences
Dr. Lisa Goldberg is the Director of Scientific Program Management at Taconic Biosciences. Lisa received a bachelor's degree in Neuroscience from Vassar College before moving to Boston University School of Medicine, where she completed her PhD in Biomedical Pharmacology and Neuroscience. During graduate school, Lisa focused on investigating the genetic underpinnings of addiction associated traits using forward genetics and genetically modified mouse models. Lisa continued her research track as a post-doctoral fellow and assistant researcher professor at Penn State University, studying the genetics of nicotine and learning. She joined Taconic in 2021 as part of the Colony Management Solutions Strategy Design Group before moving into the Scientific Program Management team. Lisa has over 14 years of experience with the management and behavioral analyses of genetically engineered mouse models.
Presenter
Jessica Ramadhin, PhD
Field Applications Scientist
Taconic Biosciences
Dr. Jessica Ramadhin received her B.A. in Biological Sciences from Cornell University and earned her Ph.D. in Infectious Diseases from the University of Georgia. During her graduate studies, she tested two anti-inflammatory compounds as therapeutics for obesity and metabolic syndrome. She then completed her postdoctoral training in the Department of Gastroenterology at Cedars-Sinai Medical Center, where she examined how myeloid-specific knockout of the glycolytic enzyme hexokinase 2 impacted rodent models of obesity, colitis, and infection. Jessica has worked with animal models for many years and has a wide range of in vivo experience related to infectious diseases, immunology, metabolism, and the gut microbiome.